Proellex Pharmacokinetics Bridging Study
NCT01067807
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
25 mg Proellex
DRUG:
25 mg Proellex
DRUG:
25 mg Proellex
DRUG:
50 mg Proellex
Sponsor
Repros Therapeutics Inc.